Skip to main content
. Author manuscript; available in PMC: 2014 Apr 1.
Published in final edited form as: Cancer Chemother Pharmacol. 2013 Jan 13;71(4):883–892. doi: 10.1007/s00280-013-2079-z

Table 3.

Circulating tumor cell (CTC) changes with treatment.

Baseline CTCs <5 (per 7.5 mL) N = 19
   Post-treatment CTCs <5 18/19 94.7%
   Post-treatment CTCs ≥5 1/19 5.3%
Baseline CTCs ≥5 (per 7.5 mL) N = 11
   Post-treatment CTCs <5 2/11 18.2%
   Post-treatment CTCs ≥5 9/11 81.8%